Item 2.02 Results of Operations and Financial Condition.
On May 11, 2021, Kronos Bio, Inc. issued a press release providing a corporate
update and announcing its financial results for the quarter ended March 31,
2021. A copy of the press release is being furnished as Exhibit 99.1 to this
Report on Form 8-K.
The information in this Report on Form 8-K and Exhibit 99.1 attached hereto is
intended to be furnished and shall not be deemed "filed" for purposes of Section
18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Exchange Act,
except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Press Release, dated May 11, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses